v3.26.1
Equity Method Investment (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Nov. 14, 2024
Nov. 13, 2024
Schedule of Equity Method Investments [Line Items]              
Net loss $ (9,317)   $ (8,248) $ (16,052) $ (14,835)    
Impairment of equity investment 641     $ 641      
Fair value          
Impairment of equity investment $ 641            
Invizyne Technologies Inc [Member]              
Schedule of Equity Method Investments [Line Items]              
Share price $ 8.43     $ 8.43      
Fair value       $ 33,100      
Shares issued       3,931,133      
Fair value after adjustment       $ 33,700      
Exozymes [Member]              
Schedule of Equity Method Investments [Line Items]              
Equity method investment, percentage           47.00% 60.00%
Net loss $ 1,260     $ 5,250      
Owned shares 3,931,133     3,931,133      
Exozymes [Member] | Maximum [Member]              
Schedule of Equity Method Investments [Line Items]              
Equity method investment, percentage           50.00%  
Invizyne Technologies Inc [Member]              
Schedule of Equity Method Investments [Line Items]              
Equity method investment, percentage 40.75%     40.75%